TSC
ROIV icon

Two Seas Capital’s Roivant Sciences ROIV Stock Holding History

Two Seas Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258M Sell
9,328,291
-463,600
-5% -$11.9M 3.61% 2
2025
Q4 		$212M Sell
9,791,891
-1,962,273
-17% -$38.7M 4.38% 4
2025
Q3 		$178M Buy
11,754,164
+1,156,124
+11% +$14.3M 2.85% 5
2025
Q2 		$119M Buy
10,598,040
+461,733
+5% +$5M 2.01% 5
2025
Q1 		$102M Sell
10,136,307
-31,500
-0.3% -$341K 3.22% 5
2024
Q4 		$120M Buy
10,167,807
+442,914
+5% +$5.24M 10.39% 2
2024
Q3 		$112M Sell
9,724,893
-593,871
-6% -$6.76M 18.18% 2
2024
Q2 		$109M Buy
10,318,764
+2,388,415
+30% +$26.2M 17.73% 2
2024
Q1 		$83.6M Sell
7,930,349
-577,874
-7% -$6.23M 16.37% 2
2023
Q4 		$95.5M Buy
8,508,223
+592,991
+7% +$5.78M 23.33% 2
2023
Q3 		$92.4M Buy
7,915,232
+5,641
+0.1% +$63.8K 18.59% 2
2023
Q2 		$79.7M Buy
7,909,591
+102,484
+1% +$917K 17.43% 2
2023
Q1 		$57.6M Buy
7,807,107
+1,396,667
+22% +$11.5M 52.88% 1
2022
Q4 		$51.2M Buy
6,410,440
+540,750
+9% +$3.01M 48.65% 1
2022
Q3 		$18.9M Buy
5,869,690
+2,449,854
+72% +$9.49M 17.26% 2
2022
Q2 		$13.9M Buy
3,419,836
+2,612,929
+324% +$10.4M 18.12% 2
2022
Q1 		$3.99M Buy
806,907
+495,862
+159% +$3.27M 3.34% 5
2021
Q4 		$3.13M Buy
+311,045
New +$2.59M 2.41% 5

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Seas Capital's ROIV Position: Q1 2026 in Review

Two Seas Capital reduced its Roivant Sciences (ROIV) stake by 4.7% in Q1 2026, selling an estimated $11.9M and leaving 9,328,291 shares worth $258M. The position accounts for 3.61% of the portfolio, ranked #2.

Two Seas Capital first reported a position in ROIV in Q4 2021 and has held it in 18 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Two Seas Capital held 9,328,291 shares of Roivant Sciences worth $258M as of Q1 2026.
  • Two Seas Capital sold 463,600 Roivant Sciences shares in Q1 2026, an estimated $11.9M.
  • Roivant Sciences made up 3.61% of Two Seas Capital's portfolio in Q1 2026, its #2 holding.
  • Two Seas Capital first reported a position in Roivant Sciences in Q4 2021 and has held it in 18 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Two Seas Capital's 13F filing for Q1 2026, filed 15 May 2026.